-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
-
-
-
-
-
-
-
Summit Therapeutics plc (SMMT) PT Lowered to $44 at H.C. Wainwright
-
-
-
-
-
-
-
Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
-
-
-
-
-
-
H.C. Wainwright Starts Summit Therapeutics plc (SMMT) at Buy
21,697 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

